- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06761378
Ideal Time of Stenting Prior to Ureteral Access Sheath for Stone Disease
December 31, 2024 updated by: Hossam Kandeel, Menoufia University
Ideal Time of Stenting Prior to Ureteral Access Sheath for Stone Disease , Two vs Four Weeks Prospective Study
The miniaturization of endourological instruments and improvements in laser lithotripsy have revolutionized the approach to renal stones .
- Flexible URS has become popular with urologists, as it is easy to learn, is associated with high stone-free rates, and is acceptable to patients.
Firstly described in 1964 by Marshall, the uretroscope was only passively deflectable and did not include working channel.
- Although the first successful procedure in humans with a ureteroscope integrating active deflection has been reported by Takayasu, it was not until 1987 that Demetrius Bagley introduced flexible ureteroscopy as we know it today ).] - two types of flexible uretroscopy can be distinguished : fiberoptic and digital flexible URS.
The difference between them is the image relay and light transmission.
- Now either to use ureteral access sheath (AS) or not , but usage of AS decrease intrarenal pressure and clear vision by drainage of dust , so , for access of AS stent better to be inserted prior to the procedure ) So, there are little publications regarding the optimal timing of the stent In this study we will assess the feasibility of passage AS after two versus four weeks from stent insertion
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The miniaturization of endourological instruments and improvements in laser lithotripsy have revolutionized the approach to renal stones .
- Flexible URS has become popular with urologists, as it is easy to learn, is associated with high stone-free rates, and is acceptable to patients.
Firstly described in 1964 by Marshall, the uretroscope was only passively deflectable and did not include working channel.
- Although the first successful procedure in humans with a ureteroscope integrating active deflection has been reported by Takayasu, it was not until 1987 that Demetrius Bagley introduced flexible ureteroscopy as we know it today ).] - two types of flexible uretroscopy can be distinguished.
The difference between them is the image relay and light transmission.
- Now either to use ureteral access sheath (AS) or not , but usage of AS decrease intrarenal pressure and clear vision by drainage of dust , so , for access of AS stent better to be inserted prior to the procedure ) So, there are little publications regarding the optimal timing of the stent In this study we will assess the feasibility of passage AS after two versus four weeks from stent insertion
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
State Or Province
-
Cairo, State Or Province, Egypt, 32511
- Menofia University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- All patients with stone kidney up to 2 cm
- failed ESWL (extracorporeal shock wave lithotripsy)
- difficult PCNL (percutaneous nephrolithotomy)
Exclusion Criteria:
- Size more than 2 cm
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 2 weeks Dj insertion
Renal stent for 2 weeks prior flexible uretroscopy
|
Renal stent before flexible uretroscopy
Renal stent for 2 weeks prior flexible uretroscopy
|
|
Active Comparator: 4weeks Dj insertion
Renal stent for 4 weeks prior flexible uretroscopy
|
Renal stent before flexible uretroscopy
Renal stent for 2 weeks prior flexible uretroscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
passage of access sheath after dilation of the ureter by DJ 2 vs 4 weeks
Time Frame: 6 months
|
Patients will classified in two groups, one will insert DJ for two weeks and the other insert DJ for four weeks then remove it and trial to insert access sheath for flexible uretroscopy duriing passage of the sheath the ureteric dilitation will be assessed if the sheath pass or not measure so , the ability of the ureteric dilitation to obtain the sheath is it dilated enough after 2 or 4 weeks
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Actual)
December 1, 2024
Study Completion (Actual)
December 4, 2024
Study Registration Dates
First Submitted
December 24, 2024
First Submitted That Met QC Criteria
December 31, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 31, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5/2024UROL2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ureteric Stone
-
Tor Erik SandUnknownUreteric Stent After Stone SurgeryNorway
-
Cairo UniversityBeni-Suef UniversityCompletedUreteric StoneEgypt
-
Hamad Medical CorporationRecruitingUreteric Stone | Stone UreterQatar
-
Assiut UniversityUnknown
-
Mansoura UniversityCompletedRenal Stone | Ureter Stone | Ureteric ObstructionEgypt
-
Zayed Military HospitalCompleted
-
Chinese University of Hong KongCompleted
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
Clinical Trials on Renal stent
-
Bursa Postgraduate HospitalCompleted
-
Abbott Medical DevicesCompletedRenal Artery Obstruction | Hypertension, RenalUnited States
-
Boston Scientific CorporationCompletedAtherosclerotic Lesions in the Aortorenal OstiumUnited States
-
Cook Group IncorporatedCompletedRenal Artery StenosisUnited States
-
Medical University of ViennaUnknown
-
Adva-TecUniversity of British ColumbiaCompletedUnilateral Ureteral Stone | Renal Stone Fragments ≤ 2mmCanada
-
UMC UtrechtCompletedRenal Artery Obstruction | Kidney FailureNetherlands
-
Biotronik AGCompletedRenal Artery StenosisGermany
-
Azienda Unita Sanitaria Locale di PiacenzaUnknownAtherosclerosis | Chronic Kidney Disease | Hypertension, Renovascular | Renal Artery Stenosis | Ischemic NephropathyItaly
-
University of Toledo Health Science CampusJohnson & Johnson; Centocor, Inc.CompletedRenal Artery StenosisUnited States